Latest News

For pancreatic cancers less than or equal to 20 mm, a deep learning model offered a nearly 45 percent higher sensitivity rate with non-contrast CT in comparison to unassisted radiologist interpretation.

Noting that frustration over slow implementation of technological advances may be contributing to mounting radiologist frustration and subsequent burnout, this author offers key principles for integrating technological solutions into radiology workflows.

In the latest episode of the Molecular Imaging in Focus series, Michael Hofman, MBBS, FRACP, discussed the potential of an emerging PET radiotracer for DVT detection spotlighted in SNMMI’s “Image of the Year,” a new advance in total body PET/CT and other highlights from the SNMMI conference.

While use of an AI software demonstrated significantly higher accuracy in evaluating BI-RADS 2 presentations and no significant difference with radiologists in BI-RADS 4 assessments of breast ultrasound in a sub-analysis, researchers noted the exclusion of galactoceles, fluid collections and skin lesions that are commonly found in pregnant and lactating women.

In a recent interview, new SNMMI president Heather Jacene, MD, discussed key goals for bolstering workforce development in nuclear medicine, improving infrastructure equity and optimizing emerging advances to facilitate precision treatments in oncology.

While perspective is important for reining in an unrelenting perfectionism here and there, the inner drive for achievement can serve as fuel for consistently high quality over the course of a radiologist’s career.

Indicated for the detection and visualization of abnormal vascularity in the central nervous system (CNS) and non-CNS body regions, gadoquatrane provides 60 percent less gadolinium dosing in comparison to other macrocyclic gadolinium (Gd)-based contrast agents (mGBCAs).

Catch up on the top radiology content of the past week.

In a recent interview, Nina Kottler, MD, discussed the challenges with traditional radiology reporting, its impact on cognitive load and the recently launched AI-enabled platform Mosaic Reporting.

In the latest episode of her “Breast Imaging in Focus” series, Manisha Bahl, MD, MPH, FSBI, discusses new research findings from a study involving over 111,000 women that suggest the potential utility of GLP-1 receptor agonists for reducing breast cancer risk.

For men with high clinical risk for prostate cancer (PCa) and a lack of significant findings on mpMRI, triage use of PSMA PET/CT resulted in a 49 percent reduction of biopsies and an 18 percent reduction in detection of clinically insignificant PCa, according to newly published research.

The AI-enabled image processing with SubtleHD(CT) software reportedly facilitates improved noise reduction and image quality for computed tomography (CT) exams.

The Reporting Pro software reportedly offers an array of AI-enabled features that may help streamline radiology reports.